Judge Approves $158M Settlement Of J&J Risperdal Suit
A Texas judge on Tuesday approved a final settlement in which a Johnson & Johnson unit will pay $158 million to end allegations that it illegally marketed antipsychotic drug Risperdal, despite...To view the full article, register now.
Already a subscriber? Click here to view full article